JP2023524274A5 - - Google Patents
Info
- Publication number
- JP2023524274A5 JP2023524274A5 JP2022566726A JP2022566726A JP2023524274A5 JP 2023524274 A5 JP2023524274 A5 JP 2023524274A5 JP 2022566726 A JP2022566726 A JP 2022566726A JP 2022566726 A JP2022566726 A JP 2022566726A JP 2023524274 A5 JP2023524274 A5 JP 2023524274A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- compound
- sars
- coronavirus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063018690P | 2020-05-01 | 2020-05-01 | |
| US63/018,690 | 2020-05-01 | ||
| PCT/US2021/029840 WO2021222534A1 (en) | 2020-05-01 | 2021-04-29 | Compounds and methods for prevention and treatment of coronavirus infections |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023524274A JP2023524274A (ja) | 2023-06-09 |
| JP2023524274A5 true JP2023524274A5 (https=) | 2024-06-14 |
| JP7805010B2 JP7805010B2 (ja) | 2026-01-23 |
Family
ID=78292168
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022566726A Active JP7805010B2 (ja) | 2020-05-01 | 2021-04-29 | コロナウイルス感染を予防および処置する化合物および方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US12433901B2 (https=) |
| EP (1) | EP4142713A1 (https=) |
| JP (1) | JP7805010B2 (https=) |
| CN (1) | CN116568295B (https=) |
| AU (1) | AU2021264554A1 (https=) |
| TW (1) | TW202206080A (https=) |
| WO (1) | WO2021222534A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2023535714A (ja) * | 2020-07-23 | 2023-08-21 | アージル・バイオテック・ホールディング・カンパニー・リミテッド | ウイルス感染を阻害するための方法および組成物 |
| US20240408055A1 (en) * | 2021-10-21 | 2024-12-12 | Peking University Shenzhen Graduate School | Use of anisomelic acid in preparation of pharmaceutical composition for inhibiting infection and replication of sars-cov-2 and variants |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20140105928A1 (en) * | 2004-01-06 | 2014-04-17 | Paul Edward Stamets | Antiviral and antibacterial activity from medicinal mushrooms |
| CA2481489A1 (en) * | 2002-11-29 | 2004-06-17 | Morinaga Milk Industry Co., Ltd. | Cysteine protease inhibitor |
| TWI389699B (zh) * | 2009-02-13 | 2013-03-21 | 高雄醫學大學 | 用於誘導細胞凋亡之樟芝子實體乙醇萃取物及其製備方法 |
| US7919665B2 (en) | 2009-02-17 | 2011-04-05 | Conocophillips Company | Mercury removal from hydrocarbons |
| TW201231474A (en) * | 2011-01-26 | 2012-08-01 | Univ Kaohsiung Medical | Triterpenoid composition of Antrodia cinnamomea, preparation and analysis method thereof |
| FI126047B (en) * | 2012-08-28 | 2016-06-15 | John Eriksson | Pharmaceutical compositions of anisomelic acid and their use |
| TWI453026B (zh) * | 2013-05-14 | 2014-09-21 | Jenisa Biotechnology Corp Ltd | 魚針草萃取物及其純化物抗流感病毒之用途 |
| US9645651B2 (en) | 2013-09-24 | 2017-05-09 | Microsoft Technology Licensing, Llc | Presentation of a control interface on a touch-enabled device based on a motion or absence thereof |
| US11253527B2 (en) * | 2019-02-25 | 2022-02-22 | Arjil Biotech Holding Company Limited | Method and composition for inhibiting virus infection |
| WO2021202982A1 (en) * | 2020-04-03 | 2021-10-07 | Turtle Bear Holdings, Llc | Compositions and methods for modulating inflammatory response |
| CN113521060B (zh) * | 2020-04-17 | 2022-12-06 | 北京大学深圳研究生院 | 鱼针草内酯抗新型冠状病毒的用途 |
| TW202200175A (zh) * | 2020-04-28 | 2022-01-01 | 浩峰生物科技股份有限公司 | 牛樟芝萃取物(Ant-Ex)減少血管收縮素轉換酶2(ACE-2)蛋白質表現 |
-
2021
- 2021-04-29 WO PCT/US2021/029840 patent/WO2021222534A1/en not_active Ceased
- 2021-04-29 CN CN202180046668.8A patent/CN116568295B/zh active Active
- 2021-04-29 EP EP21795939.4A patent/EP4142713A1/en not_active Withdrawn
- 2021-04-29 JP JP2022566726A patent/JP7805010B2/ja active Active
- 2021-04-29 AU AU2021264554A patent/AU2021264554A1/en active Pending
- 2021-04-30 US US17/245,828 patent/US12433901B2/en active Active
- 2021-05-03 TW TW110115949A patent/TW202206080A/zh unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020023528A5 (https=) | ||
| JP2018070614A5 (https=) | ||
| JP2024071370A5 (https=) | ||
| JP2022515197A5 (https=) | ||
| CN111989332A (zh) | 作为cdk抑制剂的大环化合物、其制备方法及其在医药上的应用 | |
| JP2022081661A5 (https=) | ||
| JP2022509091A5 (https=) | ||
| JP2020507589A5 (https=) | ||
| JP2020500862A5 (https=) | ||
| JP2021523112A5 (https=) | ||
| JP2024516371A5 (https=) | ||
| JP2023524274A5 (https=) | ||
| JP2008501705A5 (https=) | ||
| JP2023506787A5 (https=) | ||
| US20090060874A1 (en) | Bicyclic pyrrolidine derivatives | |
| ME00354B (me) | Novi lekovi za tretiranje hronićnog opstruktivnog oboljenja pluća | |
| RU2009102278A (ru) | Модуляторы рецептора s1p для лечения рассеянного склероза | |
| JP2021152063A5 (https=) | ||
| JP2009512659A5 (https=) | ||
| JP2022533958A5 (https=) | ||
| JP2022552881A5 (https=) | ||
| JP2022501327A5 (https=) | ||
| JP2022527556A5 (https=) | ||
| JP2021534160A5 (https=) | ||
| JP2012520321A5 (https=) |